Profile data is unavailable for this security.
About the company
Beijing Hotgen Biotech Co Ltd is a China-based company principally engaged in in-vitro diagnostics, innovative biological drugs, and biotechnology raw materials and artificial intelligence (AI) innovative drug services. The in-vitro diagnostics business mainly engages in the development and application of in-vitro diagnostic reagents and instruments. The innovative biological drug business focuses on two core areas: antibody drugs and nucleic acid drugs. The biotechnology raw materials and AI innovative drug services business mainly includes the core technology platform of biotechnology raw materials and the biomolecular AI design platform. The Company mainly operates its businesses in the domestic and overseas markets.
- Revenue in CNY (TTM)434.45m
- Net income in CNY-259.33m
- Incorporated2005
- Employees903.00
- LocationBeijing Hotgen Biotech Co LtdYard 26 Yongwang West Rd, Daxing DistBEIJING 102629ChinaCHN
- Phone+86 1 050973660
- Fax+86 1 056528861
- Websitehttps://www.hotgen.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xiangyu Medical Co Ltd | 773.93m | 73.51m | 10.88bn | 2.34k | 142.00 | 5.37 | -- | 14.06 | 0.4789 | 0.4789 | 5.07 | 12.67 | 0.2548 | 1.01 | 11.40 | 330,597.70 | 2.35 | 8.54 | 3.26 | 10.17 | 65.98 | 66.78 | 9.22 | 28.37 | 0.9871 | -- | 0.2387 | 32.49 | -0.1717 | 11.71 | -54.68 | -4.41 | 83.55 | -- |
| Shanghai Microport EP MedTech Co Ltd | 458.70m | 52.26m | 11.21bn | 500.00 | 214.59 | 6.26 | -- | 24.45 | 0.111 | 0.111 | 0.9747 | 3.81 | 0.2395 | 1.33 | 6.85 | 917,403.00 | 2.73 | 0.9084 | 2.91 | 0.9579 | 58.24 | 64.95 | 11.39 | 4.09 | 10.17 | -- | 0.0032 | 0.00 | 25.51 | 28.61 | 815.36 | -- | 35.67 | -- |
| Beijing Wandong Medical Technolgy Co Ltd | 1.62bn | 14.41m | 11.31bn | 1.19k | 965.79 | 2.42 | -- | 6.98 | 0.0167 | 0.0167 | 2.26 | 6.66 | 0.2937 | 2.73 | 2.99 | 1,360,016.00 | 0.2623 | 4.51 | 0.304 | 5.21 | 31.59 | 42.82 | 0.8933 | 14.91 | 4.80 | -- | 0.0039 | 43.25 | 23.26 | 9.18 | -16.54 | -1.40 | -1.39 | 21.06 |
| Sansure Biotech Inc | 1.67bn | 271.49m | 11.59bn | 2.35k | 45.18 | 1.63 | -- | 6.94 | 0.4427 | 0.4427 | 2.45 | 12.31 | 0.1852 | 1.04 | 2.46 | 711,687.90 | 2.50 | 21.18 | 2.81 | 24.37 | 73.70 | 68.60 | 13.49 | 40.51 | 4.49 | -- | 0.1716 | 25.74 | 44.78 | 31.89 | -24.23 | 47.50 | 65.28 | -- |
| TINAVI Medical Technologies Co Ltd | 274.20m | -159.01m | 11.60bn | 307.00 | -- | 9.29 | -- | 42.31 | -0.3493 | -0.3493 | 0.6035 | 2.74 | 0.1673 | 2.18 | 7.63 | 893,155.40 | -10.37 | -8.02 | -11.54 | -9.16 | 70.09 | 69.64 | -62.01 | -63.51 | 2.94 | -15.75 | 0.1408 | -- | -14.85 | -4.87 | 22.54 | -- | 12.71 | -- |
| Eyebright Medical Technlgy (Bjng) Co Ltd | 1.48bn | 360.97m | 11.67bn | 2.29k | 32.05 | 4.15 | -- | 7.89 | 1.88 | 1.88 | 7.71 | 14.53 | 0.4048 | 1.89 | 3.34 | 644,799.40 | 9.90 | 10.50 | 11.54 | 12.04 | 62.91 | 75.13 | 24.45 | 31.92 | 3.28 | 24.66 | 0.1753 | 20.11 | 48.24 | 48.51 | 27.77 | 42.25 | 18.40 | -- |
| Shandong Weigao Orthopaedic Devce Co Ltd | 1.48bn | 266.86m | 11.93bn | 2.07k | 44.71 | 2.93 | -- | 8.09 | 0.6672 | 0.6672 | 3.70 | 10.18 | 0.2919 | 0.7798 | 5.17 | 714,278.40 | 5.36 | 9.00 | 6.58 | 11.05 | 64.22 | 74.07 | 18.37 | 24.98 | 4.28 | -- | 0.0011 | 22.90 | 13.18 | -1.59 | 99.22 | -12.72 | -3.40 | -- |
| Vcanbio Cell & Gene Engineering Corp Ltd | 1.47bn | 74.75m | 12.09bn | 2.01k | 156.85 | 3.26 | -- | 8.21 | 0.1647 | 0.1647 | 3.29 | 7.93 | 0.2778 | 1.92 | 2.35 | 730,874.40 | 1.07 | 1.24 | 1.51 | 1.76 | 67.29 | 68.07 | 3.85 | 4.20 | 1.60 | 4.90 | 0.0219 | 0.00 | -0.2705 | 2.71 | -5.73 | 15.09 | -11.35 | -- |
| Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.25bn | 377.82m | 12.20bn | 832.00 | 31.78 | 3.08 | -- | 9.75 | 3.12 | 3.12 | 10.27 | 32.10 | 0.2694 | 1.56 | 3.66 | 1,515,185.00 | 7.94 | 15.38 | 9.10 | 16.87 | 68.10 | 75.38 | 29.45 | 41.85 | 4.36 | -- | 0.0043 | 46.52 | 1.61 | 29.30 | 1.96 | 28.78 | 58.53 | 35.76 |
| Beijing Hotgen Biotech Co Ltd | 434.45m | -259.33m | 13.37bn | 903.00 | -- | 4.56 | -- | 30.77 | -3.04 | -3.04 | 4.98 | 31.63 | 0.1313 | 1.96 | 4.23 | 481,114.30 | -7.97 | 21.79 | -8.47 | 24.93 | 56.38 | 55.43 | -60.71 | 29.14 | 4.77 | -- | 0.0168 | 44.35 | -6.74 | 19.41 | -760.40 | -- | -10.29 | -- |
| Beijing Balance Medical Technolgy Co Ltd | 591.28m | 180.33m | 14.21bn | 611.00 | 78.73 | 11.41 | -- | 24.04 | 1.31 | 1.31 | 4.29 | 9.04 | 0.4268 | 1.27 | 5.08 | 967,721.80 | 11.93 | 8.03 | 12.97 | 8.44 | 86.78 | 88.93 | 27.95 | 27.67 | 2.89 | -- | 0.0668 | 76.32 | 35.41 | 28.01 | 27.02 | 18.33 | 140.77 | 41.14 |
| Micro-Tech Nanjing Co Ltd | 3.12bn | 611.40m | 15.47bn | 2.46k | 25.25 | 3.80 | -- | 4.95 | 3.26 | 3.26 | 16.65 | 21.68 | 0.6401 | 1.93 | 6.36 | 1,267,666.00 | 13.00 | 10.56 | 15.93 | 12.61 | 64.09 | 63.46 | 20.30 | 19.11 | 3.30 | -- | 0.0626 | 33.65 | 14.26 | 16.08 | 13.85 | 12.75 | 38.21 | -- |
Data as of Feb 11 2026. Currency figures normalised to Beijing Hotgen Biotech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
28.97%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 5.87m | 6.37% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 5.50m | 5.97% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 5.31m | 5.77% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 3.01m | 3.27% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 1.51m | 1.64% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 1.33m | 1.45% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 1.19m | 1.29% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 1.05m | 1.15% |
| Great Wall Fund Management Co., Ltd.as of 30 Jun 2025 | 1.04m | 1.13% |
| ABC-CA Fund Management Co., Ltd.as of 30 Jun 2025 | 857.31k | 0.93% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
